Completed PHASE3 INTERVENTIONAL 2-arm NCT00962442

N-Acetylcysteine in Severe Acute Alcoholic Hepatitis

N-Acetylcysteine for the Treatment of Alcoholic Hepatitis: a Belgian Multicenter Randomised Trial

Sponsor: Erasme University Hospital

Updated 5 times since 2017 Last updated: Aug 19, 2009 Started: Sep 30, 2000 Primary completion: Jan 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Alcoholic Hepatitis and is currently completed. Erasme University Hospital leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasme University Hospital

Data source: Erasme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium